Hydroxyurea
Hydroxyurea capsules, USP is indicated for the treatment of: Resistant chronic myeloid leukemia. Locally advanced squamous cell carcinomas of the head and neck (excluding the lip) in combination with chemoradiation.
United States
$9
per month
India
$2
per month
You save
−76%save $6/mo · 76% cheaper
526.1K US scripts/yr$3.4M potential annual savings$4.5M US spend/yr
Drag to rotate · 3D structureCH4N2O2
SMILES: C(=O)(N)NO
Compare the price
US price$9per month
India price$2per month
You save$676% less
Based on 30 units per month. US $0.29 vs India $0.07 per unit.
Total over 1 periodSave $6$9 → $2
The bigger picture
Hydroxyurea is filled about 526.1K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$4.5M
If sourced from India
$1.1M
Potential annual savings
$3.4M
−76%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.